Bioventus (BVS) Long-Term Deferred Tax (2021 - 2026)

Bioventus' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $5.5 million for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 16.38% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 16.38% YoY) and the FY2025 annual result came in at $5.5 million, up 16.38% from the prior year.
• Long-Term Deferred Tax was $5.5 million for Q1 2026 at Bioventus, roughly flat from $5.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $7.4 million in Q3 2024 and bottomed at $4.7 million in Q4 2024.
• A 3-year average of $5.5 million and a median of $5.1 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Peak annual rise in Long-Term Deferred Tax reached 16.38% in 2025, while the deepest fall reached 35.84% in 2025.
• Bioventus' Long-Term Deferred Tax stood at $4.7 million in 2024, then grew by 16.38% to $5.5 million in 2025, then changed by 0.0% to $5.5 million in 2026.
• Business Quant data shows BVS's Long-Term Deferred Tax at $5.5 million in Q1 2026, $5.5 million in Q4 2025, and $4.7 million in Q3 2025.